Legal Medicine
Volume 11, Issue 6 , Pages 294-297, November 2009

A fatal case of myocardial damage due to misuse of the “designer drug” MDMA

  • Rie Sano

      Affiliations

    • Department of Legal Medicine, Gunma University, Graduate School of Medicine, Maebashi 371-8511, Japan
  • ,
  • Toshikazu Hasuike

      Affiliations

    • Advanced Medical Emergency and Critical Care Center, Maebashi Red Cross Hospital, Maebashi 371-0014, Japan
  • ,
  • Minoru Nakano

      Affiliations

    • Advanced Medical Emergency and Critical Care Center, Maebashi Red Cross Hospital, Maebashi 371-0014, Japan
  • ,
  • Yoshihiko Kominato

      Affiliations

    • Department of Legal Medicine, Gunma University, Graduate School of Medicine, Maebashi 371-8511, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 27 220 8030; fax: +81 27 220 8035.
  • ,
  • Hideaki Itoh

      Affiliations

    • Department of Pathology and Clinical Laboratories, Maebashi Red Cross Hospital, Maebashi 371-0014, Japan

Received 23 April 2009; received in revised form 27 July 2009; accepted 16 September 2009. published online 15 October 2009.

Abstract 

A 39-year-old woman collapsed after oral intake of 3,4-methylenedioxymethyl-amphetamine (MDMA, “ecstasy”). After ingestion of the drug, she had felt persistent discomfort in her anterior chest area, and lost consciousness for a few minutes on the following morning. She was transported to a hospital and died seven days after collapse. A serum sample obtained on admission revealed an MDMA concentration of 1.2mg/L, but no evidence of any other drug including amphetamine, methamphetamine, or other ring-substituted amphetamines. Microscopic examination at autopsy revealed striking changes in the heart, including small foci of myocyte necrosis with a surrounding macrophage inflammatory response, foci of fibrosis, and calcification accompanied by myocyte necrosis, these changes being predominant in the right ventricle. In the liver, hepatic necrosis was observed with fatty degeneration accompanied by inflammation. Myoglobinuria was demonstrated in the kidney by immunohistochemistry. Degeneration of neurons throughout the whole brain was also evident, in addition to haemorrhagic foci in the pons and medulla. Serious bronchopneumonia was also found in the right lung. These findings provide evidence that oral intake of MDMA can result in cardiotoxicity, inducing cardiac arrhythmia and cardiovascular collapse. As a consequence of the compromised blood supply, brain necrosis may occur, followed by severe bronchopneumonia. Ingestion of MDMA could also lead to liver damage as well as myoglobinuria resulting from rhabdomyolysis. These data suggest that death in this case had been caused largely by MDMA intoxication.

Keywords: MDMA, Myocardial damage, Myoglobinuria

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1344-6223(09)00328-9

doi:10.1016/j.legalmed.2009.09.003

Legal Medicine
Volume 11, Issue 6 , Pages 294-297, November 2009